ArticleCureus2025
Dedifferentiated Liposarcoma of the Spermatic Cord: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spermatic cord liposarcomas are rare malignant neoplasms with no established level-one evidence-based treatment guidelines. Well-differentiated liposarcomas (WDL) lack metastatic potential but can transform into dedifferentiated liposarcomas (DDL), which are more aggressive. Due to the rarity of these tumors, treatment recommendations are primarily based on retrospective studies and extrapolated data from extremity sarcomas. We report a case of a DDL managed with radical orchiectomy and en bloc resection, along with a literature review on spermatic cord liposarcomas, focusing on imaging, histopathology, and treatment strategies. Imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), aid in tumor characterization, while histopathological examination remains the gold standard for diagnosis. Surgical management prioritizes R0 resection, as incomplete excision is associated with high recurrence rates. The role of adjuvant therapy remains controversial, with limited evidence supporting its routine use. In our case, complete resection with negative margins was achieved, and clinical follow-up was chosen over adjuvant treatment. Given the aggressive nature of high-grade liposarcomas and their tendency for local recurrence, wide surgical excision with negative margins remains the primary treatment. The role of adjuvant chemotherapy and radiotherapy is unclear and may be considered in high-risk cases. Further research is needed to establish standardized treatment protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.